Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Filter
  • 1-10 ل  15,181 نتائج ل ""denosumab""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Report

Study of Denosumab for Prevention of Skeletal Disease Progression in Children With Fibrous Dysplasia

  • Source: A Phase 2 Study of Denosumab for Prevention of Skeletal Disease Progression in Children With Fibrous Dysplasia

تفاصيل العنوان

×
Report

DEnosumab for the Treatment of FIbrous Dysplasia/McCune-Albright Syndrome in Adults (DeFiD) (DeFiD)

  • Authors : Natasha Appelman-Dijkstra, Principal investigator, Internist-Endocrinologist, MD, PhD

  • Source: DEnosumab for the Treatment of FIbrous Dysplasia/McCune-Albright Syndrome in Adults (DeFiD): a Randomized Double-blind Placebo-controlled Trial

تفاصيل العنوان

×
Report

Studying the Effect of Denosumab on Preventing Breast Cancer in Women with a BRCA1 Germline Mutation (BRCA-P)

  • Source: BRCA-P: a Randomized, Double-Blind, Placebo-Controlled, Multi-Center, International Phase 3 Study to Determine the Preventive Effect of Denosumab on Breast Cancer in

تفاصيل العنوان

×
Report

Denosumab for the Treatment of Adult LCH

  • Source: Evaluation of Efficacy of Denosumab in Adult Patients With Langerhans Cell Histiocytosis (LCH): a Multiple-site, Single Arm, Open Label Clinical TrialMakras P,

تفاصيل العنوان

×
Academic Journal

Denosumab combined with radiotherapy as an alternative to surgery for advanced metastatic bone lesions and pathologic fractures: a retrospective case study of 38 patients.

  • Authors : Farhang M; Department of Diagnostics and Intervention, Orthopedics, Umeå University, Umeå, Sweden. .; Isaksson M

Subjects: Denosumab*/Denosumab*/Denosumab*/therapeutic use ; Denosumab*/Denosumab*/Denosumab*/administration & dosage ; Bone Neoplasms*/Bone Neoplasms*/Bone Neoplasms*/secondary

  • Source: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2024 Dec 01; Vol. 63, pp. 932-938. Date of Electronic Publication: 2024 Dec 01.Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 8709065 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of HLX14 versus reference denosumab in healthy males: A randomized phase I study.

  • Authors : Li N; Clinical Pharmacology Research Center, Huashan Hospital, Fudan University, Shanghai, China.; Chu N

Subjects: Denosumab*/Denosumab*/Denosumab*/pharmacokinetics ; Denosumab*/Denosumab*/Denosumab*/administration & dosage ; Denosumab*/Denosumab*/Denosumab*/adverse effects

  • Source: Clinical and translational science [Clin Transl Sci] 2024 Dec; Vol. 17 (12), pp. e70089.Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Report

A Study of Denosumab in Multiple Myeloma Patients with Renal Insufficiency

  • Source: A Phase 2, Single-Arm Study of Denosumab in Multiple Myeloma Patients with Renal Insufficiency

تفاصيل العنوان

×
Report

Efficacy of Romosozumab and Denosumab Combined Treatment in Postmenopausal Osteoporosis Patients with Multiple Fragility Fractures (MORD)

  • Source: Efficacy of Romosozumab and Denosumab Combined Treatment in Postmenopausal Osteoporosis Patients with Multiple Fragility FracturesAdami G, Pedrollo E, Rossini M,

تفاصيل العنوان

×
  • 1-10 ل  15,181 نتائج ل ""denosumab""